TyraTech, Inc. Director's Dealings (3763E)
April 08 2014 - 1:10PM
UK Regulatory
TIDMTYR TIDMTYRU
RNS Number : 3763E
TyraTech, Inc.
08 April 2014
8 April 2014
TyraTech, Inc.
("TyraTech" or the "Company")
Director's Dealings
TyraTech, Inc. (AIM: TYR and TYRU), a natural life sciences
company, announces that, it was notified today that, on 7 April
2014, Mr Alan Reade and his wife, Mrs Alyson Reade, sold 202,500
Common shares of US$0.001 per share (AIM: TYR) ("TyraTech shares");
at a price of 11.80 pence per TyraTech share.
Mr & Mrs Reade then immediately repurchased 197,500 Common
shares at 11.82 pence per TyraTech share; these shares being
acquired equally into their respective ISA accounts.
Following these transactions, Alan Reade's beneficial interest
in the Company has reduced by 5,000 TyraTech shares to 12,481,358
TyraTech shares representing approximately 6.09% of the Company's
issued share capital.
For further information please contact:
TyraTech Inc.
Alan Reade, Non-Executive Chairman Tel: +44 7841978709
Bruno Jactel, Chief Executive Officer Tel: +1 919 415 4340
SPARK Advisory Partners Limited, Nominated Adviser
Matt Davis / Mark Brady Tel: +44203 368 3552
Tel: +44203 368 3551
Allenby Capital Limited , Joint Broker
Chris Crawford Tel: +44 20 3328 5656
Whitman Howard Limited, Joint Broker
Ranald McGregor-Smith / Niall Devins Tel: +44 20 7087 4555
Walbrook, Financial PR and IR
Bob Huxford /Guy McDougall (Public Relations) Tel: +44 20 7933 8792
Paul Cornelius (Investor Relations) Tel: +44 20 7933 8794
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSSSMFWAFLSESL
Tyratech (LSE:TYR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Tyratech (LSE:TYR)
Historical Stock Chart
From Jul 2023 to Jul 2024